Abstract. Ginsenoside Rb 1 (GRb 1 ), a major component of the traditional herb ginseng, has been reported to show a neuroprotective effect in a rodent ischemic model. The purpose of this study was to investigate effects of GRb 1 on early and delayed brain injuries in a non-human primate thromboembolic stroke model. Thromboembolic stroke was induced by occlusion of the middle cerebral artery by injection of an autologous blood clot into the left internal carotid artery. GRb 1 (300 µg /kg per day, i.v.) and vehicle were administered from 7 days before embolization to the day following embolization (total: 8 times). Neurological deficits were observed at 1, 6, and 24 h and at 2, 4, and 7 days after embolization. At 7 days after embolization, neuron damage in the peri-infarct area and core region were assessed by NeuN, TUNEL, and GFAP staining. GRb 1 improved the skeletal muscle coordination score of the neurologic deficits (median: GRb 1 vs vehicle = 10 vs 12, P<0.05). In the GRb 1 group, positive neurons expressed by NeuN staining were noted in the ischemic peri-infarct area, and TUNEL-and GFAP-positive cells significantly decreased, when compared with vehicle. These results demonstrated that GRb 1 ameliorated both early and delayed injuries in the thromboembolic stroke model in non-human primates.